I have a little black hole

"Yes boss, and I have a new idea. Boss, you can let the Biyi Group increase the proportion of research investment in biopharmaceuticals, let them invest more angel investment funds, and invest in those who have ideas but do not have Fund research and development teams and individuals in biological aspects of laboratory specific experiments and let them do their own research!

Regardless of whether they can produce any results, we are more pleased with the results and can continue to increase investment without disappointment without concrete results.

Because even if their research is wrong, or there is not much benefit from the results, their research data and R&D process are also a big gain. At least it can make our company's headquarters a lot less. Detour, save more R&D time!

I think at the current development speed of Biyi Group and your boss’s behind-the-scenes support, it is very easy for them to invest US$5 billion in the biopharmaceutical field every year.

And our company can also allow our angel investment department to make angel investment in the biopharmaceutical field. The funds here are more adequate, and it is no problem to invest 10 billion US dollars every year!

These investments on the bright side can basically achieve global investment in multiple biopharmaceutical fields with more than 15 billion US dollars invested every year!

These investments can bring huge R&D data to the company, and after these data are integrated on the company side, the company’s R&D database can become very substantial, and the company can have more data when conducting relevant R&D. support!

We can also use our own private funds to invest in related fields. The day-to-day investment management company under my control can be responsible for investment in this area. At our current capital scale, investing another 15 billion US dollars in investment is also a sprinkling thing!

This money can be invested in companies and countries that are hostile to us. With a little money, they can help us carry out research and development work in various fields of biopharmaceuticals. I am happy to think about it!

This combination of investment on the surface and investment in the dark, together, we will invest more than 30 billion US dollars in angel investment funds in a year, I believe we can greatly promote the research and development process in the field of biopharmaceuticals!

After all, the amount of our investment is more than the global total investment in the biopharmaceutical field every year. If so much money is invested, it can’t promote the research and development process in related fields.

After all, our investment is not an investment that fully pursues interests. Some biological research and development work with little profit has almost no way to obtain angel investment, but these researches abandoned by capital are also very valuable things for us!

For example, your boss also knows that the hotspots of investment in the biopharmaceutical field are now in the research of anti-cancer drugs and other related new drugs. Very few pharmaceutical companies conduct research on the research and development of some minority diseases. Even if there is, Large companies will only do it after receiving state subsidies, and the drugs developed are all expensive drugs!

But no one is willing to study more minority diseases, just because such research is not much benefit even if it is researched, capital is pursuing profits, and few people who lose money are willing to do it!

But our company can invest in these minority diseases in angel investment abroad. On the one hand, it can increase the social impact of our company. On the other hand, I think that the research on these minority diseases is also very good. importance!

These unknown diseases caused by genetic diseases that are still very new to the field of biopharmaceuticals, or known diseases with only tens of thousands of patients, I think if we can do more research work on their genetic diseases, It will allow us to grasp our human genes more accurately.

Moreover, it is possible to conduct more in-depth research on how to solve real genetic diseases, which will bring more data and R&D experience to our company's future research work on more complex space genetic diseases.

This is very important for the future of the company. After all, in the space environment, it is possible to have any mutations in our human genes. If we do not have the research preparation for this, we will suffer in the future!

This is my idea. I hope that you, the boss, will allow our company’s biopharmaceutical research to involve experts from all over the world, and the research of these people will also allow our company’s biopharmaceutical company to get very huge data to feed back. It also allows them to maintain maximum enthusiasm for work. After all, so many competitors are also conducting relevant research, and they will be eliminated if they do not work hard!"

Kuafu introduced his thoughts in detail, and his thoughts also proved that his current wisdom has been able to think independently. This is an incredible thing for artificial intelligence, but it is for intelligent life. It's another normal thing, once again proves that Kuafu can now be regarded as a junior intelligent life!

"Good! Kuafu, your idea is very good! Although 30 billion US dollars a year is not a small number, but we still give it up, and it does not mean that these investments will be floated, there will always be benefits in the future, saying Maybe an investment will surprise us!

Anyway, angel investment is such a thing, investing in 100 projects, as long as one can succeed, it can make up for the loss, if there are a few more projects to succeed, then you can make money, we may have the most investment in the next year Just need to invest 10 billion US dollars!

I think we will lose up to US$10 billion a year at most, and we still lose money. And the R&D data in these investments is our biggest gain. We can buy these R&D with a loss of US$10 billion a year. Data, I also feel very worthwhile!

Then our own investment will be handed over to your day-to-day investment management company. I will explain it to the Biyi Group. As for the company, I will tell Jiang Yuting!"Lei Tiantang said happily.

Biomedicine refers to the use of research results in microbiology, biology, medicine, biochemistry, etc. from organisms, biological tissues, cells, organs, body fluids, etc.A class of products for the prevention, treatment and diagnosis made by comprehensive use of scientific principles and methods such as microbiology, chemistry, biochemistry, biotechnology, and pharmacy.

And there are too many research categories involved in this field. The only thing is to rely on a biopharmaceutical company established in the Lei Tiantang plan to study. When only there will be results, only Tian will know.